ClinicalTrials.Veeva

Menu

Breast 3DUS ABUS System Comparison

W

Western University, Canada

Status

Enrolling

Conditions

Breast Diseases

Treatments

Device: 3D Ultrasound Image Acquisition

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This comparative study will recruit 30 females who are scheduled for mammography and ultrasound assessment. The clinical 2D ultrasound is performed routinely, and the research portion of this study will add a few extra 3-D ultrasound images during the procedure. The ultrasound imaging laboratory under the direction of Dr. Aaron Fenster has developed a customized device designed to acquire 3D ultrasound of the breast using a commercial ultrasound machine. The purpose is to see how well 3-dimensional ultrasound acquire from that device is able to visualize tumours and other key features in comparison to the clinical system InveniaTM developed by GE Medical.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult Patients who are scheduled for screening ABUS
  • Adults Patients who are scheduled for short term follow-up with ABUS.
  • Must be at least 18 years of age or older.
  • Must be proficient in English (reading/writing).

Exclusion criteria

  • Patients with breast implants.
  • Patients with contraindication for ABUS.
  • Patients who cannot tolerate ABUS.

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Patients at Risk of Breast Cancer
Experimental group
Description:
These patients will be imagined with an experimental device designed to acquire ultrasound in three dimensional volumes
Treatment:
Device: 3D Ultrasound Image Acquisition

Trial contacts and locations

1

Loading...

Central trial contact

Anat Kornecki, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems